Demonstration of Sufficient Evidence and Regulatory Strategy Alignment in the Clinical Evaluation Process
Webinar , United StatesDemonstration of Sufficient Evidence and Regulatory Strategy Alignment in the Clinical Evaluation Process In the first part of our webinar series, we discussed Legacy Devices, WET devices, and devices exempt from Clinical Investigations under Article 61, along with the need for data sufficiency and how significant changes impact the route to conformity. In this webinar, […]